Skip to main content
. 2020 Dec 1;320:141–147. doi: 10.1016/j.ijcard.2020.08.013

Table 2.

Echocardiographic parameters.

Controls (n = 25) Donors (n = 23) p value
IVSD (mm) 10 (9–11) 10 (8–11) 0.106
LVIDD (mm) 44 ± 4 44 ± 5 0.946
PWD (mm) 9 (8–10) 9 (8–10) 0.732
LVIDS (mm) 28 ± 3 29 ± 4 0.470
Fractional Shortening (%) 36 (31–38) 32 (31–36) 0.201
LVEDVi (ml/m2) 46 ± 8 47 ± 10 0.716
LVESVi (ml/m2) 17 (14–19) 18 (13−22) 0.713
EF (%) 62 (60–65) 61 (57–65) 0.305
TAPSE (mm) 21 ± 3 20 ± 3 0.168
GLS (%) −19 ± 3 −19 ± 3 0.849
LV mass index (g/m2) 71 (62–88) 69 (57–76) 0.307
LV geometry n(%) – normal geometry 17 (68) 14 (61) 0.439
 Concentric remodelling 6 (24) 9 (39)
 Eccentric hypertrophy 1 (4)
 Concentric hypertrophy 1 (4)
Left atrial volume index (ml/m2) 19.3 ± 4.3 20.5 ± 6.8 0.477
E/A ratio 1.2 ± 0.3 1.1 ± 0.2 0.184
E/e’ 6 (5–8) 6 (6–7) 0.655

Data are presented as mean ± SD or median (IQR). IVSD – interventricular septal diameter, LVIDD – left ventricular internal diameter diastole, PWD – posterior wall diameter, LVIDS – left ventricular internal diameter systole, LVEDVi – indexed left ventricular end diastolic volume, LVESVi – indexed left ventricular end systolic volume, EF – ejection fraction, TAPSE – tricuspid annular plane systolic excursion, GLS – global longitudinal strain, LV – left ventricular.